Bolt Biotherapeutics (BOLT) Cash from Financing Activities (2020 - 2026)

Bolt Biotherapeutics (BOLT) posted Cash from Financing Activities of $6000.0 for Q1 2026, up 20.0% sequentially from $5000.0 in Q4 2025.

Bolt Biotherapeutics (BOLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Bolt Biotherapeutics has reported Cash from Financing Activities for 7 years, with the latest figure at $6000.0 in Q1 2026.

Quarterly Cash from Financing Activities changed N/A year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25000.0 (down 76.85% YoY) and the FY2025 annual result came in at $19000.0, down 82.41% from the prior year.
Cash from Financing Activities grew to $6000.0 in Q1 2026 per BOLT's latest filing, from $5000.0 in the prior quarter.
Over five years, Cash from Financing Activities peaked at $252000.0 in Q2 2022 and troughed at $5000.0 in Q4 2025.
A 5-year average of $82444.4 and a median of $79000.0 in 2024 frame the typical range for Cash from Financing Activities.
The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities sank 99.96% in 2022, then decreased 26.39% in 2023.
Over 5 years, Cash from Financing Activities stood at $144000.0 in 2022, then declined by 26.39% to $106000.0 in 2023, then sank by 72.64% to $29000.0 in 2024, then tumbled by 82.76% to $5000.0 in 2025, then rose by 20.0% to $6000.0 in 2026.
According to Business Quant data, Cash from Financing Activities over the past three periods registered $6000.0, $5000.0, and $14000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-426.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1.22 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	14.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-6.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.24 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-16.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.18 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-273.15 Mn
10	Bolt Biotherapeutics	6.10 Mn	6.10 Mn	-	19,000.00

Download Data